Male, 67 y/o

Patient internal ID: 649200378

ICD-10 code

C61 Malignant neoplasm of prostate.

Diagnosis (incl metastases/stage) and year

May 2019
The patient was diagnosed with stage 4 moderately differentiated prostate adenocarcinoma G3 (Gleason 4+3=7) with metastases in bones and lungs.

Previous treatment

Surgery (orchiectomy), hormone therapy (Prednisolone, Enzalutamide), chemotherapy (Docetaxel, Cabazitaxel).

Prognosis and survival expectation

Patients diagnosed at stage 4, five-year survival rate is approximately 29%.

Treatment provided

Autologous DCV and CIK. Immunotherapy has been applied since October 2021 to March 2022.
In 2023 the patient has received a course of PTAC.

Patient survival/condition and year

Stable disease, ongoing hormonotherapy. The patient enjoys life and has only follow-up.